212 related articles for article (PubMed ID: 32901121)
1. UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance.
Huang Y; Yang X; Lu Y; Zhao Y; Meng R; Zhang S; Dong X; Xu S; Wu G
Cell Death Differ; 2021 Feb; 28(2):671-684. PubMed ID: 32901121
[TBL] [Abstract][Full Text] [Related]
2. S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer.
Huang Y; Hu K; Zhang S; Dong X; Yin Z; Meng R; Zhao Y; Dai X; Zhang T; Yang K; Liu L; Huang K; Shi S; Zhang Y; Chen J; Wu G; Xu S
Theranostics; 2018; 8(5):1286-1300. PubMed ID: 29507620
[No Abstract] [Full Text] [Related]
3. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.
Chen S; Yang J; Zhang Y; Duan C; Liu Q; Huang Z; Xu Y; Zhou L; Xu G
J Biol Chem; 2018 Jul; 293(29):11296-11309. PubMed ID: 29871923
[TBL] [Abstract][Full Text] [Related]
4. Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer.
Yang X; Zeng Z; Jie X; Wang Y; Han J; Zheng Z; Li J; Liu H; Dong X; Wu G; Xu S
Cancer Lett; 2022 Apr; 532():215594. PubMed ID: 35149174
[TBL] [Abstract][Full Text] [Related]
5. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
6. USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription.
Jie X; Fong WP; Zhou R; Zhao Y; Zhao Y; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S
Cell Death Differ; 2021 Jul; 28(7):2095-2111. PubMed ID: 33558705
[TBL] [Abstract][Full Text] [Related]
7. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
Ullah K; Zubia E; Narayan M; Yang J; Xu G
FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
[TBL] [Abstract][Full Text] [Related]
8. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
9. A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy.
Vila IK; Yao Y; Kim G; Xia W; Kim H; Kim SJ; Park MK; Hwang JP; González-Billalabeitia E; Hung MC; Song SJ; Song MS
Cancer Cell; 2017 Feb; 31(2):208-224. PubMed ID: 28162974
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
11. UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.
Ma M; Zhang C; Cao R; Tang D; Sang X; Zou S; Wang X; Xu H; Liu G; Dai L; Tian Y; Gao X; Fu X
Oncogene; 2022 Nov; 41(48):5199-5213. PubMed ID: 36273042
[TBL] [Abstract][Full Text] [Related]
12. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
13. Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.
Zhang X; Zhang J; Bauer A; Zhang L; Selinger DW; Lu CX; Ten Dijke P
EMBO J; 2013 Apr; 32(7):996-1007. PubMed ID: 23455153
[TBL] [Abstract][Full Text] [Related]
14. UBE2O is a quality control factor for orphans of multiprotein complexes.
Yanagitani K; Juszkiewicz S; Hegde RS
Science; 2017 Aug; 357(6350):472-475. PubMed ID: 28774922
[TBL] [Abstract][Full Text] [Related]
15. β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.
Ma J; Lu Y; Zhang S; Li Y; Huang J; Yin Z; Ren J; Huang K; Liu L; Yang K; Wu G; Xu S
Cell Death Differ; 2018 Aug; 25(8):1473-1485. PubMed ID: 29396548
[TBL] [Abstract][Full Text] [Related]
16. UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair.
Huang Q; Qin D; Pei D; Vermeulen M; Zhang X
FASEB J; 2022 Jan; 36(1):e22112. PubMed ID: 34921745
[TBL] [Abstract][Full Text] [Related]
17. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
18. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
Vila IK; Park MK; Setijono SR; Yao Y; Kim H; Badin PM; Choi S; Narkar V; Choi SW; Chung J; Moro C; Song SJ; Song MS
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292296
[TBL] [Abstract][Full Text] [Related]
19. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.
Queisser MA; Dada LA; Deiss-Yehiely N; Angulo M; Zhou G; Kouri FM; Knab LM; Liu J; Stegh AH; DeCamp MM; Budinger GR; Chandel NS; Ciechanover A; Iwai K; Sznajder JI
Am J Respir Crit Care Med; 2014 Sep; 190(6):688-98. PubMed ID: 25118570
[TBL] [Abstract][Full Text] [Related]
20. Mxi1 participates in the progression of lung cancer via the microRNA-300/KLF9/GADD34 Axis.
Lei Y; Huang Y; Lin J; Sun S; Che K; Shen J; Liao J; Chen Y; Chen K; Lin Z; Lin X
Cell Death Dis; 2022 May; 13(5):425. PubMed ID: 35501353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
